Published in J Am Med Inform Assoc on May 30, 2013
Are interventions to reduce interruptions and errors during medication administration effective?: a systematic review. BMJ Qual Saf (2013) 1.05
Paving the COWpath: data-driven design of pediatric order sets. J Am Med Inform Assoc (2014) 0.89
Cost-effectiveness analysis of a hospital electronic medication management system. J Am Med Inform Assoc (2015) 0.80
Natural Language Processing-Enabled and Conventional Data Capture Methods for Input to Electronic Health Records: A Comparative Usability Study. JMIR Med Inform (2016) 0.75
Hospital electronic prescribing system implementation impact on discharge information communication and prescribing errors: a before and after study. Eur J Clin Pharmacol (2017) 0.75
Technology-induced errors associated with computerized provider order entry software for older patients. Int J Clin Pharm (2017) 0.75
An Ethnographic Study of Health Information Technology Use in Three Intensive Care Units. Health Serv Res (2017) 0.75
Role of computerized physician order entry systems in facilitating medication errors. JAMA (2005) 26.32
Unexpected increased mortality after implementation of a commercially sold computerized physician order entry system. Pediatrics (2005) 15.40
Some unintended consequences of information technology in health care: the nature of patient care information system-related errors. J Am Med Inform Assoc (2003) 14.71
Types of unintended consequences related to computerized provider order entry. J Am Med Inform Assoc (2006) 7.86
Safe electronic health record use requires a comprehensive monitoring and evaluation framework. JAMA (2010) 2.53
Prescription errors and outcomes related to inconsistent information transmitted through computerized order entry: a prospective study. Arch Intern Med (2009) 2.45
"e-Iatrogenesis": the most critical unintended consequence of CPOE and other HIT. J Am Med Inform Assoc (2007) 2.40
Mixed results in the safety performance of computerized physician order entry. Health Aff (Millwood) (2010) 2.19
Does computerized provider order entry reduce prescribing errors for hospital inpatients? A systematic review. J Am Med Inform Assoc (2009) 2.09
The impact of CPOE medication systems' design aspects on usability, workflow and medication orders: a systematic review. Methods Inf Med (2009) 2.03
Technology induced error and usability: the relationship between usability problems and prescription errors when using a handheld application. Int J Med Inform (2005) 1.98
Using FDA reports to inform a classification for health information technology safety problems. J Am Med Inform Assoc (2011) 1.86
Errors associated with outpatient computerized prescribing systems. J Am Med Inform Assoc (2011) 1.62
Medication errors related to computerized order entry for children. Pediatrics (2006) 1.38
An unintended consequence of electronic prescriptions: prevalence and impact of internal discrepancies. J Am Med Inform Assoc (2010) 1.36
Effects of two commercial electronic prescribing systems on prescribing error rates in hospital in-patients: a before and after study. PLoS Med (2012) 1.22
Errors and electronic prescribing: a controlled laboratory study to examine task complexity and interruption effects. J Am Med Inform Assoc (2010) 1.16
Failure to utilize functions of an electronic prescribing system and the subsequent generation of 'technically preventable' computerized alerts. J Am Med Inform Assoc (2012) 1.11
The influence of computerized decision support on prescribing during ward-rounds: are the decision-makers targeted? J Am Med Inform Assoc (2011) 1.05
MicroRNAs modulate hematopoietic lineage differentiation. Science (2003) 30.05
A global double-fluorescent Cre reporter mouse. Genesis (2007) 17.86
Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity. Proc Natl Acad Sci U S A (2008) 17.41
Rheb promotes cell growth as a component of the insulin/TOR signalling network. Nat Cell Biol (2003) 5.01
Drosophila's insulin/PI3-kinase pathway coordinates cellular metabolism with nutritional conditions. Dev Cell (2002) 4.85
Genomic binding by the Drosophila Myc, Max, Mad/Mnt transcription factor network. Genes Dev (2003) 4.68
CareTrack: assessing the appropriateness of health care delivery in Australia. Med J Aust (2012) 4.46
A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol (2008) 4.43
Myc-dependent regulation of ribosomal RNA synthesis during Drosophila development. Nat Cell Biol (2005) 3.80
MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. PLoS One (2009) 3.66
Assessment of diclofenac or spinal manipulative therapy, or both, in addition to recommended first-line treatment for acute low back pain: a randomised controlled trial. Lancet (2007) 3.58
Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart. J Biol Chem (2002) 3.22
Histone methylation by PRC2 is inhibited by active chromatin marks. Mol Cell (2011) 3.14
Acute kidney injury and aberrant planar cell polarity induce cyst formation in mice lacking renal cilia. Hum Mol Genet (2008) 3.14
Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation. Proc Natl Acad Sci U S A (2012) 3.03
Association of interruptions with an increased risk and severity of medication administration errors. Arch Intern Med (2010) 2.81
Role of toll-like receptor signalling in Abeta uptake and clearance. Brain (2006) 2.70
A randomized controlled trial of Licartin for preventing hepatoma recurrence after liver transplantation. Hepatology (2007) 2.66
Effectiveness of bevacizumab with first-line combination chemotherapy for Medicare patients with stage IV colorectal cancer. J Clin Oncol (2012) 2.59
Clinical pharmacokinetics of metformin. Clin Pharmacokinet (2011) 2.59
The Trithorax group protein Lid is a trimethyl histone H3K4 demethylase required for dMyc-induced cell growth. Genes Dev (2007) 2.57
The road to consensus: considerations for the safe use and prescribing of COX-2-specific inhibitors. Med J Aust (2002) 2.37
PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury. J Clin Invest (2005) 2.36
Spinal stenosis prevalence and association with symptoms: the Framingham Study. Spine J (2009) 2.32
Evaluating medicines: let's use all the evidence. Med J Aust (2007) 2.32
Role of SCN5A Y1102 polymorphism in sudden cardiac death in blacks. Circulation (2005) 2.25
A benefit-risk assessment of benzbromarone in the treatment of gout. Was its withdrawal from the market in the best interest of patients? Drug Saf (2008) 2.24
Pethidine in emergency departments: promoting evidence-based prescribing. Med J Aust (2005) 2.18
Isolation of a novel population of multipotent adult stem cells from human hair follicles. Am J Pathol (2006) 2.13
Does computerized provider order entry reduce prescribing errors for hospital inpatients? A systematic review. J Am Med Inform Assoc (2009) 2.09
The influences of hyperprolactinemia and obesity on cardiovascular risk markers: effects of cabergoline therapy. Clin Endocrinol (Oxf) (2006) 2.09
Hepatic suppression of Foxo1 and Foxo3 causes hypoglycemia and hyperlipidemia in mice. Endocrinology (2011) 2.07
Death and morbidity from supratherapeutic dosing of colchicine. Med J Aust (2011) 2.02
PLX4032, a potent inhibitor of the B-Raf V600E oncogene, selectively inhibits V600E-positive melanomas. Pigment Cell Melanoma Res (2010) 2.02
Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer disease. J Biol Chem (2007) 1.98
Institutional prescreening for detection and eradication of methicillin-resistant Staphylococcus aureus in patients undergoing elective orthopaedic surgery. J Bone Joint Surg Am (2010) 1.92
Myostatin regulates cardiomyocyte growth through modulation of Akt signaling. Circ Res (2006) 1.92
Shikonin circumvents cancer drug resistance by induction of a necroptotic death. Mol Cancer Ther (2007) 1.90
Evidence for the formation of a novel nitrosothiol from the gaseous mediators nitric oxide and hydrogen sulphide. Biochem Biophys Res Commun (2006) 1.82
Prospective study of iliac crest bone graft harvest site pain and morbidity. Spine J (2009) 1.80
Fibrinogen is required for maintenance of platelet intracellular and cell-surface P-selectin expression. Blood (2009) 1.79
ICP27 recruits Aly/REF but not TAP/NXF1 to herpes simplex virus type 1 transcription sites although TAP/NXF1 is required for ICP27 export. J Virol (2005) 1.77
Adhesion, migration and communication in melanocytes and melanoma. Pigment Cell Res (2005) 1.76
Obesity induces signs of premature cardiac aging in younger patients: the role of mitochondria. J Am Coll Cardiol (2011) 1.76
Medical specialists and pharmaceutical industry-sponsored research: a survey of the Australian experience. Med J Aust (2005) 1.75
Development and characterization of polymorphic microsatellite markers in Cyclobalanopsis glauca (Fagaceae). Am J Bot (2012) 1.72
The effect of hydrogen sulfide donors on lipopolysaccharide-induced formation of inflammatory mediators in macrophages. Antioxid Redox Signal (2010) 1.72
Spondylolysis and spondylolisthesis: prevalence and association with low back pain in the adult community-based population. Spine (Phila Pa 1976) (2009) 1.71
The VPS33B-binding protein VPS16B is required in megakaryocyte and platelet α-granule biogenesis. Blood (2012) 1.67
Platelet-associated complement factor H in healthy persons and patients with atypical HUS. Blood (2009) 1.67
Toll-like receptor 4-dependent upregulation of cytokines in a transgenic mouse model of Alzheimer's disease. J Neuroinflammation (2008) 1.67
Association between degenerative spondylolisthesis and spinous process fracture after interspinous process spacer surgery. Spine J (2012) 1.66
Transcriptional effects of chronic Akt activation in the heart. J Biol Chem (2002) 1.65
Subsidised access to TNF alpha inhibitors: is the rationale for exclusion of rheumatoid-factor-negative patients defensible? Med J Aust (2004) 1.65
Facet joint osteoarthritis and low back pain in the community-based population. Spine (Phila Pa 1976) (2008) 1.64
PE, a new sulfated saponin from sea cucumber, exhibits anti-angiogenic and anti-tumor activities in vitro and in vivo. Cancer Biol Ther (2005) 1.64
Abnormal megakaryocyte development and platelet function in Nbeal2(-/-) mice. Blood (2013) 1.64
Pervasive nanoscale deformation twinning as a catalyst for efficient energy dissipation in a bioceramic armour. Nat Mater (2014) 1.62
Mild traumatic brain injury among a cohort of rugby union players: predictors of time to injury. Br J Sports Med (2011) 1.60
Hydrogen sulphide: a novel endogenous gasotransmitter facilitates erectile function. J Sex Med (2007) 1.59
The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings. Inflammopharmacology (2013) 1.56
Requirement of VPS33B, a member of the Sec1/Munc18 protein family, in megakaryocyte and platelet alpha-granule biogenesis. Blood (2005) 1.52
Activation of stress response gene SIRT1 by BCR-ABL promotes leukemogenesis. Blood (2011) 1.52
Hypoxia induces phenotypic plasticity and therapy resistance in melanoma via the tyrosine kinase receptors ROR1 and ROR2. Cancer Discov (2013) 1.52
Systematic review of the effectiveness of hyperbaric oxygenation therapy in the management of chronic diabetic foot ulcers. Mayo Clin Proc (2013) 1.50
Risk factors associated with fluoroquinolone-resistant tuberculosis in a Beijing tuberculosis referral hospital. Respirology (2011) 1.50
Realignment treatment for medial tibiofemoral osteoarthritis: randomised trial. Ann Rheum Dis (2012) 1.50
PKP2 mutations in sudden death from arrhythmogenic right ventricular cardiomyopathy (ARVC) and sudden unexpected death with negative autopsy (SUDNA). Circ J (2011) 1.48
Pancreatic stone protein/regenerating protein (PSP/reg): a novel secreted protein up-regulated in type 2 diabetes mellitus. Endocrine (2014) 1.47
Mutations in NBEAL2, encoding a BEACH protein, cause gray platelet syndrome. Nat Genet (2011) 1.47
Structure of spheroidal HDL particles revealed by combined atomistic and coarse-grained simulations. Biophys J (2007) 1.45
Retrograde intrarenal surgery for the treatment of renal stones: is fluoroscopy-free technique achievable? Urolithiasis (2015) 1.44
The endoglin(positive) sca-1(positive) rhodamine(low) phenotype defines a near-homogeneous population of long-term repopulating hematopoietic stem cells. Immunity (2003) 1.42
Characteristics and treatment outcomes of patients with MDR and XDR tuberculosis in a TB referral hospital in Beijing: a 13-year experience. PLoS One (2011) 1.42
Water resources: groundwater maintains dune landscape. Nature (2004) 1.40
2-deoxy-D-glucose causes cytotoxicity, oxidative stress, and radiosensitization in pancreatic cancer. Free Radic Biol Med (2007) 1.40
Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol (2004) 1.40
A mass spectrometric determination of the conformation of dimeric apolipoprotein A-I in discoidal high density lipoproteins. Biochemistry (2005) 1.40
Novel changes in discoidal high density lipoprotein morphology: a molecular dynamics study. Biophys J (2006) 1.39
Utility of urine drug screening: a clinical audit. Emerg Med Australas (2007) 1.39
Lipoprotein-like particles and cholesteryl esters in human Bruch's membrane: initial characterization. Invest Ophthalmol Vis Sci (2005) 1.39
Sudden coronary death caused by pathologic intimal thickening without atheromatous plaque formation. Cardiovasc Pathol (2009) 1.38
The slow-releasing hydrogen sulfide donor, GYY4137, exhibits novel anti-cancer effects in vitro and in vivo. PLoS One (2011) 1.37
Blue-light-dependent interaction of cryptochrome 1 with SPA1 defines a dynamic signaling mechanism. Genes Dev (2011) 1.36
2-Deoxy-D-glucose-induced cytotoxicity and radiosensitization in tumor cells is mediated via disruptions in thiol metabolism. Cancer Res (2003) 1.34
Necrostatin-1 reverts shikonin-induced necroptosis to apoptosis. Apoptosis (2009) 1.33
CD4 and CD8 T-lymphocyte apoptosis can predict radiation-induced late toxicity: a prospective study in 399 patients. Clin Cancer Res (2005) 1.32
Lack of LDL receptor aggravates learning deficits and amyloid deposits in Alzheimer transgenic mice. Neurobiol Aging (2005) 1.32
Structures of discoidal high density lipoproteins: a combined computational-experimental approach. J Biol Chem (2009) 1.32
The role of BRAF mutation and p53 inactivation during transformation of a subpopulation of primary human melanocytes. Am J Pathol (2009) 1.31
Hydrogen sulfide-induces DNA damage and changes in apoptotic gene expression in human lung fibroblast cells. FASEB J (2006) 1.30
Adverse event reporting in clinical trials: room for improvement. Med J Aust (2003) 1.29
Divergence of function in the hot dog fold enzyme superfamily: the bacterial thioesterase YciA. Biochemistry (2008) 1.28
Towards the delivery of appropriate health care in Australia. Med J Aust (2012) 1.27
Defining the conditions for the generation of melanocytes from human embryonic stem cells. Stem Cells (2006) 1.27
Evolution of the chalcone-isomerase fold from fatty-acid binding to stereospecific catalysis. Nature (2012) 1.25
Waist-to-height ratio is an accurate and easier index for evaluating obesity in children and adolescents. Obesity (Silver Spring) (2007) 1.24
Targeting radioimmunotherapy of hepatocellular carcinoma with iodine (131I) metuximab injection: clinical phase I/II trials. Int J Radiat Oncol Biol Phys (2006) 1.23